Subscribe to RSS
  • Published Re...
    The FDA has released its Performance ...

    Published Report: FDA on GDUFA

    The FDA has released its Performance Report for the first year of the Generic Drug User Fee Amendments (PDF downloadable ...
  • Careers ...
    New Initiative Designed to Reward ...

    Careers … Young Scientist Scholarship Launched by iIroko Pharma & Penn

    New Initiative Designed to Reward Philadelphia Students Pursuing Higher Education in the Sciences.
  • A Potential ...
    The ghost of ‘Patent Cliff’ has ...

    A Potential Game Changer For Pharma R&D

    The ghost of ‘Patent Cliff’ has been haunting the ‘Big Pharma’ since quite some time. This situation has been further ...
  • Questcor Pha...
    ANAHEIM, Calif., Questcor Pharmaceuticals, Inc. (NASDAQ: ...

    Questcor Pharmaceuticals Expands Senior Management Team

    ANAHEIM, Calif., Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced the appointment of Rajesh (Raj) Asarpota as the Company's new Chief Financial ...

Pharmaceuticalshow all pharmaceutical articles

Questcor Pharmaceuticals Expands Senior Management Team
Questcor Pharmaceuticals Expands Senior Management Team

ANAHEIM, Calif., Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced the appointment of Rajesh (Raj) Asarpota as the Company’s new Chief Financial Officer, effective February 17, 2014. Michael H. Mulroy, the Company’s current CFO, will become Executive Vice President, Strategic Affairs and General Counsel, and spend increased time on the Company’s recently announced initiative to investigate and

FDA Extends Comment Period on Draft Guidance that Could Require an IND for Cosmetics, Dietary Supplements and Food Research
FDA Extends Comment Period on Draft Guidance that Could Require an IND for Cosmetics, Dietary Supplements and Food Research

In September 2013, the FDA issued a draft Guidance titled, “Investigational New Drug Applications (INDs) — Determining Whether Human Research Studies Can Be Conducted Without an IND.”

Published Report: FDA on GDUFA
Published Report: FDA on GDUFA

The FDA has released its Performance Report for the first year of the Generic Drug User Fee Amendments (PDF downloadable at http://1.usa.gov/1dquler).

read more

Advertising & Marketingshow all advertising & marketing articles

FDA Wakes Up to Social Media’s Ability to Monitor Drug Adverse Events
FDA Wakes Up to Social Media’s Ability to Monitor Drug Adverse Events

Alec Gaffney reports that a recent FDA Notice of Solicitation (#1127679) calls for a “contractor capable of providing it with social media monitoring services capable of analyzing consumer sentiment and social media ‘buzz’” (read “Once Again, FDA Seeks to Leverage Social Media to Uncover Adverse Events and Public Sentiment“).”

Med Ad News Announces Manny Awards Call for Entries
Med Ad News Announces Manny Awards Call for Entries

Med Ad News will honor the best in pharmaceutical and healthcare advertising at the 25th Anniversary Manny Awards on Thursday, April 24, 2014.

Concentric Pharma Advertising Wins Agency Award
Concentric Pharma Advertising Wins Agency Award

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, was named Agency of the Year at the Med Ad News 22nd Annual Manny Awards. The Manny Awards honor the best in pharmaceutical and healthcare advertising.

read more

Eventsshow all events articles

Amgen To Present At The RBC Capital Markets’ Global Healthcare Conference
Amgen To Present At The RBC Capital Markets’ Global Healthcare Conference

THOUSAND OAKS, Calif., Amgen (NASDAQ: AMGN) will present at the RBC Capital Markets’ Global Healthcare Conference at 4:05 p.m. ET on Wednesday, Feb. 26, 2014, at the New York Palace Hotel in New York City.

Arena International Events to Hold CTS in Boston
Arena International Events to Hold CTS in Boston

Arena International Events will hold this year’s Clinical Trial Supply event in Boston, MA, March 11-12. The event will build upon the success of the previous years’ conference and continue the innovative focus on smaller to mid sized biotech and pharmaceutical firms.

Pharma Expo to Partner with PACK EXPO International in November
Pharma Expo to Partner with PACK EXPO International in November

Pharma EXPO will co-locate with PACK EXPO International, November 2 – 5, 2014, at McCormick Place in Chicago. Registration will open in Spring 2014. The show will focus on all phases of pharmaceutical manufacturing and its supply chain and conference sessions and exhibits to deliver:

read more
Questcor Pharmaceuticals Expands Senior Management Team
Questcor Pharmaceuticals Expands Senior Management Team

ANAHEIM, Calif., Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced the appointment of Rajesh (Raj) Asarpota as the Company’s new Chief Financial

Published Report: FDA on GDUFA
Published Report: FDA on GDUFA

The FDA has released its Performance Report for the first year of the Generic Drug User Fee Amendments (PDF downloadable

RXi Pharmaceuticals Appoints Seasoned Experts to Scientific Advisory Board
RXi Pharmaceuticals Appoints Seasoned Experts to Scientific Advisory Board

New SAB members to lend critical skills complementary with company’s clinical development of RXI-109.  RXi Pharmaceuticals Corporation, a publicly traded

Fulcrum Forms Strategic Agreement with Ricerca Biosciences
Fulcrum Forms Strategic Agreement with Ricerca Biosciences

Great Falls, Virginia (Vocus/PRWEB) March 03, 2011 Fulcrum Pharma, an Aptiv Solutions company, a leading provider of drug development consulting

Sanford-Burnham Collaborates with Ortho-McNeil-Janssen
Sanford-Burnham Collaborates with Ortho-McNeil-Janssen

Sanford-Burnham Medical Research Institute (Sanford-Burnham) has entered into a collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., (OMJPI) to discover compounds for Alzheimer’s

read more

Research & Developmentshow all research & development articles

Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies

Agreement to Combine Merck’s Investigational Anti-PD-1 and Key Pfizer Oncology Assets.) Pfizer Inc. (NYSE:PFE) announced that it has agreed with

Bayshore Announces Expedited Review of ANDA Submission
Bayshore Announces Expedited Review of ANDA Submission

Bayshore Pharmaceuticals LLC (“Bayshore”) is pleased to announce the acknowledgment from U.S. FDA of “expedited review” status for its most

read more

Regulatory Newsshow all regulatory news articles

New Disclosure & Privacy Rules Challenge Biomedical Research Operations
New Disclosure & Privacy Rules Challenge Biomedical Research Operations

The long wait is finally over for much-anticipated regulations governing disclosure of pharmaceutical company payments to physicians, and on the

Things to Know About the Latest Final Interim Rules to Patent Term Adjustment
Things to Know About the Latest Final Interim Rules to Patent Term Adjustment

The U.S. Patent and Trademark Office (USPTO) published interim final rules revising several patent term adjustment (PTA) provisions in view

read more

Login Status

You are not currently logged in.






» Register
» Lost your Password?
banner
banner

Contacts and information

FDA RegWatch is an affiliate of MedMarket Intelligence, LLC -- a health care solutions organization. Visit us at:t: http://www.MedMarketIntel.com

Social networks

Most popular categories

Buy This Theme
© 2011 Gadgetine Wordpress theme by orange-themes.com All rights reserved.
Powered by WishList Member - Membership Software